HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice.

AbstractUNLABELLED:
Obesity is a calorie-excessive state associated with high risk of diabetes, atherosclerosis, and certain types of tumors. Obesity may induce inflammation and insulin resistance (IR). We found that the expression of interferon (IFN) regulatory factor 9 (IRF9), a major transcription factor mediating IFN responses, was lower in livers of obese mice than in those of their lean counterparts. Furthermore, whole-body IRF9 knockout (KO) mice were more obese and had aggravated IR, hepatic steatosis, and inflammation after chronic high-fat diet feeding. In contrast, adenoviral-mediated hepatic IRF9 overexpression in both diet-induced and genetically (ob/ob) obese mice showed markedly improved hepatic insulin sensitivity and attenuated hepatic steatosis and inflammation. We further employed a yeast two-hybrid screening system to investigate the interactions between IRF9 and its cofactors. Importantly, we identified that IRF9 interacts with peroxisome proliferator-activated receptor alpha (PPAR-α), an important metabolism-associated nuclear receptor, to activate PPAR-α target genes. In addition, liver-specific PPAR-α overexpression rescued insulin sensitivity and ameliorated hepatic steatosis and inflammation in IRF9 KO mice.
CONCLUSION:
IRF9 attenuates hepatic IR, steatosis, and inflammation through interaction with PPAR-α.
AuthorsXin-An Wang, Ran Zhang, Dingsheng Jiang, Wei Deng, Shumin Zhang, Shan Deng, Jinfeng Zhong, Tao Wang, Li-Hua Zhu, Li Yang, Shufen Hong, Sen Guo, Ke Chen, Xiao-Fei Zhang, Zhigang She, Yingjie Chen, Qinglin Yang, Xiao-Dong Zhang, Hongliang Li
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 58 Issue 2 Pg. 603-16 (Aug 2013) ISSN: 1527-3350 [Electronic] United States
PMID23471885 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 by the American Association for the Study of Liver Diseases.
Chemical References
  • Dietary Fats
  • IRF9 protein, mouse
  • Interferon-Stimulated Gene Factor 3, gamma Subunit
  • PPAR gamma
Topics
  • Adenoviridae (genetics)
  • Animals
  • Dietary Fats (adverse effects)
  • Disease Models, Animal
  • Fatty Liver (physiopathology)
  • Female
  • Insulin Resistance (physiology)
  • Interferon-Stimulated Gene Factor 3, gamma Subunit (deficiency, genetics, physiology)
  • Liver (physiopathology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Obese
  • Obesity (chemically induced, genetics, physiopathology)
  • PPAR gamma (physiology)
  • Sex Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: